Alberta Investment Management Corp (AIMCo)’s Supernus Pharmaceuticals SUPN Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio SUPN Stock Details SUPN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-14,142	Closed	-$425K	–	1180
2023 Q2	$425K	Hold	14,142	–	–	﹤0.01%	981
2023 Q1	$512K	Sell	14,142 -1,527	-10%	-$58.7K	0.01%	962
2022 Q4	$559K	Buy	+15,669	New	+$545K	﹤0.01%	907
2021 Q3	–	Sell	-31,500	Closed	-$970K	–	1007
2021 Q2	$970K	Hold	31,500	–	–	0.01%	782
2021 Q1	$825K	Hold	31,500	–	–	0.01%	709
2020 Q4	$793K	Sell	31,500 -12,900	-29%	-$278K	0.01%	716
2020 Q3	$925K	Buy	44,400 +15,800	+55%	+$359K	0.01%	682
2020 Q2	$679K	Buy	+28,600	New	+$632K	0.01%	769
2018 Q2	–	Sell	-18,600	Closed	-$852K	–	886
2018 Q1	$852K	Buy	+18,600	New	+$776K	0.01%	609

Other funds holding SUPN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s SUPN Position: Q3 2023 in Review

Alberta Investment Management Corp (AIMCo) sold out of Supernus Pharmaceuticals (SUPN) in Q3 2023, closing a stake of 14,142 shares — an estimated $425K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in SUPN in Q1 2018 and held it in 9 quarters. The position peaked at $970K in Q2 2021. 238 funds tracked by Wall St. Rank hold SUPN as of Q3 2023.

Alberta Investment Management Corp (AIMCo) reported no remaining Supernus Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 14,142 Supernus Pharmaceuticals shares in Q3 2023, an estimated $425K.
Alberta Investment Management Corp (AIMCo) first reported a position in Supernus Pharmaceuticals in Q1 2018 and held it in 9 quarters.
Alberta Investment Management Corp (AIMCo)'s Supernus Pharmaceuticals position peaked at $970K in Q2 2021.
238 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q3 2023.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2023, filed 14 Nov 2023.